(Q44220347)

1 December 2017

Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea (English)

1 reference

1 December 2017

0 references

Masoud Nahavandi

1

1 reference

1 December 2017

Fatemeh Tavakkoli

2

1 reference

1 December 2017

Melville Q Wyche

3

1 reference

1 December 2017

Elliott Perlin

4

1 reference

1 December 2017

William P Winter

5

1 reference

1 December 2017

Oswaldo Castro

6

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

British Journal of Haematology

1 December 2017

1 reference

1 December 2017

119

1 reference

1 December 2017

3

1 reference

1 December 2017

855-857

1 reference

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03919.X

Crossref

reference URL

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03919.X

Crossref

reference URL

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03919.X

Crossref

reference URL

10.1046/J.1365-2141.2002.03919.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference